Search research articles
Contact Us
Filters
Showing results (21-30 of 59) with videos related to
Page
of 6
Sort By:
Case Reports in Hematology
|
October 31, 2019
Aplasia in Chronic Phase CML Post-TKI Therapy: A Management Dilemma
Jeremy L Ramdial, Luis E Aguirre, Robert A Ali, et al.
Expert Opinion on Pharmacotherapy
|
April 30, 2013
5-Azacytidine for the treatment of myelodysplastic syndromes
Janusz Krawczyk, Niamh Keane, Ciara Louise Freeman, et al.
Expert Opinion on Investigational Drugs
|
August 13, 2013
Perifosine--a new option in treatment of acute myeloid leukemia?
Janusz Krawczyk, Niamh Keane, Ronan Swords, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 10, 2009
Cdc7 kinase - a new target for drug development
Ronan Swords, Devalingam Mahalingam, Michael O'Dwyer, et al.
Current Drug Targets
|
October 29, 2009
Targeting sarcomas: novel biological agents and future perspectives
Devalingam Mahalingam, Alain Mita, Kamalesh Sankhala, et al.
Leukemia & Lymphoma
|
July 13, 2023
A retrospective validation of the IPSS-M molecular score in primary and therapy-related myelodysplastic syndromes (MDS)
Jean M G Sabile, Andy Kaempf, Kaitlyn Tomic, et al.
European Journal of Clinical Investigation
|
May 3, 2012
Developmental Therapeutics Consortium report on study design effects on trial outcomes in chronic myeloid leukaemia
Francis Giles, François-Xavier Mahon, Bjorn Gjertsen, et al.
Emergency Radiology
|
June 16, 2007
Sacral insufficiency fracture complicated by epidural haematoma and cauda equina syndrome in a patient with multiple myeloma
Carmel G Cronin, Derek G Lohan, Ronan Swords, et al.
Current Drug Targets
|
July 23, 2011
The Pim kinases: new targets for drug development
Ronan Swords, Kevin Kelly, Jennifer Carew, et al.
AJR. American Journal of Roentgenology
|
October 22, 2009
Bone biopsy of new suspicious bone lesions in patients with primary carcinoma: prevalence and probability of an alternative diagnosis
Carmel G Cronin, Thomas Cashell, Jennifer Ni Mhuircheartaigh, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 59) with videos related to
Sort By:
Page
of 6
Case Reports in Hematology
|
October 31, 2019
Aplasia in Chronic Phase CML Post-TKI Therapy: A Management Dilemma
Jeremy L Ramdial, Luis E Aguirre, Robert A Ali, et al.
Expert Opinion on Pharmacotherapy
|
April 30, 2013
5-Azacytidine for the treatment of myelodysplastic syndromes
Janusz Krawczyk, Niamh Keane, Ciara Louise Freeman, et al.
Expert Opinion on Investigational Drugs
|
August 13, 2013
Perifosine--a new option in treatment of acute myeloid leukemia?
Janusz Krawczyk, Niamh Keane, Ronan Swords, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 10, 2009
Cdc7 kinase - a new target for drug development
Ronan Swords, Devalingam Mahalingam, Michael O'Dwyer, et al.
Current Drug Targets
|
October 29, 2009
Targeting sarcomas: novel biological agents and future perspectives
Devalingam Mahalingam, Alain Mita, Kamalesh Sankhala, et al.
Leukemia & Lymphoma
|
July 13, 2023
A retrospective validation of the IPSS-M molecular score in primary and therapy-related myelodysplastic syndromes (MDS)
Jean M G Sabile, Andy Kaempf, Kaitlyn Tomic, et al.
European Journal of Clinical Investigation
|
May 3, 2012
Developmental Therapeutics Consortium report on study design effects on trial outcomes in chronic myeloid leukaemia
Francis Giles, François-Xavier Mahon, Bjorn Gjertsen, et al.
Emergency Radiology
|
June 16, 2007
Sacral insufficiency fracture complicated by epidural haematoma and cauda equina syndrome in a patient with multiple myeloma
Carmel G Cronin, Derek G Lohan, Ronan Swords, et al.
Current Drug Targets
|
July 23, 2011
The Pim kinases: new targets for drug development
Ronan Swords, Kevin Kelly, Jennifer Carew, et al.
AJR. American Journal of Roentgenology
|
October 22, 2009
Bone biopsy of new suspicious bone lesions in patients with primary carcinoma: prevalence and probability of an alternative diagnosis
Carmel G Cronin, Thomas Cashell, Jennifer Ni Mhuircheartaigh, et al.
Page
of 6